查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447710

肠外营养袋市场：到 2031 年按腔室类型、消费者和最终用户划分的全球预测

Parenteral Nutrition Bags Market by Chamber Type (Single-Chamber Bags, Dual-Chamber Bags, Multi-Chambered Bags), Consumer (Adults, Children), End User (Healthcare Facilities, Pharmacies & Compounding Service Providers) - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 111 Pages | 订单完成后即时交付

价格

预计到 2031 年，全球肠外营养袋市场将达到 12.5 亿美元，2024 年至 2031 年复合年增长率为 6.6%。

该报告基于全面的一手和二手研究以及对市场情景的深入分析，提供了该行业的关键驱动因素、限制因素以及市场驱动因素/挑战。 该市场是由全球营养不良盛行率上升、早产数量增加以及代谢紊乱发病率上升所推动的。

此外，家庭医疗保健的日益普及、全球老年人口的增加以及新兴经济体为该市场带来了巨大的成长机会。 然而，对肠外营养相关感染风险的担忧正在限制该市场的成长。 新兴国家对肠外营养缺乏认知是影响肠外营养袋市场成长的主要挑战。

在腔室类型中，单腔肠外营养袋细分市场预计将在 2024 年占据肠外营养袋市场的最大份额。 单室肠外营养袋是将电解质、胺基酸、脂类、维生素、碳水化合物、微量元素等营养液全面配製并储存于一个隔间中，用于肠外给药。 此细分市场所占份额较大的原因是单室空袋的广泛使用、单室营养袋的处方率高、感染风险降低、处方和剂量错误风险降低。袋子数量较少，与两室或多室袋相比更具成本效益。

在消费者中，预计到 2024 年，成人细分市场将占据肠外营养袋市场的最大份额。 手术数量的增加、住院率的上升、老年人口的增加以及成人胃肠道疾病盛行率的增加是支撑最大市场份额的因素。 例如，2020年，罗马全球流行病学研究基金会透露，世界上有40%的人患有肠脑交互作用障碍（DGBI），如肠躁症、功能性消化不良和功能性腹痛症候群。它。 这些患者大多数需要肠外营养袋来获得所需的营养。

在最终用户中，医疗机构预计到 2024 年将占据肠外营养袋市场的最大份额。 此细分市场占有较大的市场份额是由于到医院、诊所诊治疾病的患者数量较多、疾病负担增加、肠外营养处方率增加、配药量增加等因素造成的。医院附属药房拥有先进的配药装置.

对全球肠外营养袋市场区域状况的详细分析提供了五个关键区域的详细定性和定量见解。 预计到2024年，北美将占据全球肠外营养袋市场的最大份额，其次是欧洲、亚太地区、拉丁美洲以及中东和非洲。 这种增长主要是由于慢性病和传染病的流行、早产儿数量的增加以及家庭护理环境的日益采用而导致对肠外营养的需求增加。 例如，根据世界卫生组织 (WHO) 的数据，2020 年约有 1,340 万名婴儿早产（妊娠 37 週前）。 由于无法口服餵养，早产儿通常必须进行肠外餵养，从而增加了对肠外营养的需求并支持市场成长。

目录

第 1 章简介

第 2 章研究方法

第 3 章执行摘要

第 4 章市场洞察

  • 市场
  • 摘要
  • 影响市场成长的因素
    • 市场动态影响分析
    • 因素分析
  • 主要趋势
    • 越来越多地采用居家医疗保健
    • 扩大乙烯醋酸乙烯酯 (EVA) 在胃肠外应用的使用
  • 监理分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
    • 拉丁美洲
      • 巴西
      • 墨西哥
    • 中东/非洲
  • 波特五力分析

第 5 章肠外营养袋市场：依腔室类型

  • 摘要
  • 单室肠外营养袋
  • 双室肠外营养袋
  • 多室肠外营养袋

第 6 章肠外营养袋市场：依消费者分类

  • 摘要
  • 成人
  • 儿童

第 7 章肠外营养袋市场：依最终使用者划分

  • 摘要
  • 医疗设施
  • 药局/配药服务提供者

第 8 章肠外营养袋市场：依地区

  • 摘要
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第 9 章竞争分析

  • 摘要
  • 产品组合分析
  • 竞争基准测试

第 10 章公司简介

  • B. Braun SE
  • Baxter International, Inc.
  • Fresenius Kabi Ag（A Subsidiary of Fresenius SE & Co. KGaA）
  • GVS S.p.A.
  • Grifols, S.A.
  • Technoflex
  • RENOLIT SE
  • Valmed s.r.l.
  • HEMEDIS GmbH
  • INFRA Srl
  • Beijing L&Z Medical Technology Development Co., Ltd.
  • Boen Healthcare Co., Ltd
  • AdvaCare Pharma
  • Diffuplast S.r.l.

第 11 章附录

Product Code: MRHC - 1041109

The global parenteral nutrition bags market is projected to reach $1.25 billion by 2031, at a CAGR of 6.6% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, restraints, challenges, and opportunities of the industry. This market is driven by the rising global prevalence of malnutrition, the large number of premature births, and the increasing incidence of metabolic disorders.

Furthermore, the growing adoption of home healthcare, the rising global geriatric population, and emerging economies provide significant growth opportunities for this market. However, concerns over the infection risks associated with parenteral nutrition restrain the growth of this market. The lack of awareness regarding parenteral nutrition in developing countries is a major challenge impacting the growth of the parenteral nutrition bags market.

Among chamber types, in 2024, the single-chamber parenteral nutrition bags segment is expected to account for the largest share of the parenteral nutrition bags market. Single-chamber parenteral nutrition bags are designed to compound and store a comprehensive blend of nutritional solutions, including electrolytes, amino acids, lipids, vitamins, carbohydrates, and trace elements within a single compartment for parenteral administration. The large share of the segment is attributed to the wide availability of single-chamber empty bags, high rate of prescription for single-chamber nutrition bags, decreased risk of infection, less prescription & administration errors, and cost-effectiveness as compared to dual or multi-chambered bags.

Among consumers, in 2024, the adults segment is expected to account for the largest share of the parenteral nutrition bags market. The rising number of surgeries, rising hospitalization rates, the growth of the geriatric population, and the increasing prevalence of gastrointestinal disorders among adults are factors supporting the largest share of the market. For instance, in 2020, the Rome Foundation of Global Epidemiology Study revealed that 40% of people worldwide suffer from diseases of the gut-brain interaction (DGBIs), such as irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome, among others. Most of these patients would require parenteral nutrition bags for the intake of the required nutrition.

Among end users, in 2024, the healthcare facilities segment is expected to account for the largest share of the parenteral nutrition bags market. The large market share of this segment is attributed to factors such as a large number of patients visiting hospitals and clinics for disease diagnosis and treatment, growing disease burden, an associated rise in the rates of prescription for parenteral nutrition, and the presence of advanced compounding equipment in the hospital associated compounding pharmacies.

An in-depth analysis of the geographical scenario of the global parenteral nutrition bags market provides detailed qualitative and quantitative insights for the five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the global parenteral nutrition bags market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This growth is primarily driven by the growing demand for parenteral nutrition due to the prevalence of chronic & infectious diseases, the rising number of premature births, and the growing adoption of home healthcare settings. For instance, according to the World Health Organization (WHO), in 2020, approximately 13.4 million babies were born preterm (before the completion of 37 weeks of gestation). Preterm babies often require nutrients that need to be provided parenterally since oral nutrition is not possible, therefore increasing the demand for parenteral nutrition and supporting the growth of the market.

The key players operating in the global parenteral nutrition bags market are B. Braun SE (Germany), Baxter International, Inc. (U.S.), Fresenius Kabi AG (Germany), GVS S,p.A. (Italy), Grifols, S.A. (Spain), Technolflex (France), RENOLIT Healthcare (Germany), Valmed s.r.l (Italy), HEMEDIS GmbH (Germany), INFRA Srl (Italy), Beijing L&Z Medical Technology Development Co., Ltd.(China), Boen Healthcare Co., Ltd. (China), AdvaCare Pharma (U.S.), and Diffuplast S.r.l. (Italy).

Scope of the Report:

Parenteral Nutrition Bags Market Assessment-by Chamber Type

  • Single-Chamber Parenteral Nutrition Bags
  • Dual-Chamber Parenteral Nutrition Bags
  • Multi-Chambered Parenteral Nutrition Bags

Parenteral Nutrition Bags Market Assessment-by Consumer

  • Adults
  • Children

Parenteral Nutrition Bags Market Assessment-by End User

  • Healthcare Facilities
  • Pharmacies and Compounding Service Providers

Parenteral Nutrition Bags Market-by Geography

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition and Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews With Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Key Trends
    • 4.3.1. Growing Adoption of Home Healthcare
    • 4.3.2. Growing Use of Ethylene Vinyl Acetate (EVA) in Parenteral Applications
  • 4.4. Regulatory Analysis
    • 4.4.1. North America
      • 4.4.1.1. U.S.
      • 4.4.1.2. Canada
    • 4.4.2. Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. China
      • 4.4.3.2. Japan
      • 4.4.3.3. India
    • 4.4.4. Latin America
      • 4.4.4.1. Brazil
      • 4.4.4.2. Mexico
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of Substitutes
    • 4.5.4. Threat of New Entrants
    • 4.5.5. Degree of Competition

5. Parenteral Nutrition Bags Market Assessment- by Chamber Type

  • 5.1. Overview
  • 5.2. Single-chamber Parenteral Nutrition Bags
  • 5.3. Dual-chamber Parenteral Nutrition Bags
  • 5.4. Multi-chambered Parenteral Nutrition Bags

6. Parenteral Nutrition Bags Market Assessment-by Consumer

  • 6.1. Overview
  • 6.2. Adults
  • 6.3. Children

7. Parenteral Nutrition Bags Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Healthcare Facilities
  • 7.3. Pharmacies & Compounding Service Providers

8. Parenteral Nutrition Bags Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
  • 8.3. Europe
  • 8.4. Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Product Portfolio Analysis
  • 9.3. Competitive Benchmarking

10. Company Profiles

  • 10.1. B. Braun SE
  • 10.2. Baxter International, Inc.
  • 10.3. Fresenius Kabi Ag (A Subsidiary of Fresenius SE & Co. KGaA)
  • 10.4. GVS S.p.A.
  • 10.5. Grifols, S.A.
  • 10.6. Technoflex
  • 10.7. RENOLIT SE
  • 10.8. Valmed s.r.l.
  • 10.9. HEMEDIS GmbH
  • 10.10. INFRA Srl
  • 10.11. Beijing L&Z Medical Technology Development Co., Ltd.
  • 10.12. Boen Healthcare Co., Ltd
  • 10.13. AdvaCare Pharma
  • 10.14. Diffuplast S.r.l.

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports
  • Table 1 Healthcare Expenditure as a Percentage of GDP, by Country, 2020 Vs. 2021 (%)
  • Table 2 Number of Physicians Per 1,000 Population, by Country, 2020
  • Table 3 Infant Mortality Rates (Deaths Per 1,000 Live Births), by Country, 2010 Vs. 2019 Vs. 2021
  • Table 4 Global Prevalence of Undernourishment (% of Population), by Country, 2021
  • Table 5 Canada: Medical Device Approval Procedures, by Class
  • Table 6 China: Medical Device Approval Procedures, by Class
  • Table 7 Rest of APAC: Authorities Regulating Medical Devices, by Country
  • Table 8 Brazil: Medical Device Approval Procedures, by Class
  • Table 9 Rest of Latin America: Medical Device Regulatory Systems
  • Table 10 South Africa: Medical Device Approval Procedures, by Class
  • Table 11 Global Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 12 Global Single-Chamber Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 13 Global Dual-Chamber Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 14 Global Multi-Chambered Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 15 Global Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 16 Global Parenteral Nutrition Bags Market for Adults, by Region, 2022-2031(USD Million)
  • Table 17 Global Parenteral Nutrition Bags Market for Children, by Region, 2022-2031 (USD Million)
  • Table 18 Global Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 19 Global Parenteral Nutrition Bags Market for Healthcare Facilities, by Region, 2022-2031 (USD Million)
  • Table 20 Global Parenteral Nutrition Bags Market for Pharmacies & Compounding Service Providers, by Region, 2022-2031 (USD Million)
  • Table 21 Global Parenteral Nutrition Bags Market, by Region, 2022-2031 (USD Million)
  • Table 22 North America: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 23 North America: Parenteral Nutrition Bags Market, by Consumer, 2022-2031(USD Million)
  • Table 24 North America: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 25 Europe: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 26 Europe: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 27 Europe: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 28 Asia-Pacific: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 29 Asia-Pacific: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 30 Asia-Pacific: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 31 Latin America: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 32 Latin America: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 33 Latin America: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 34 Middle East & Africa: Parenteral Nutrition Bags Market, by Chamber Type, 2022-2031 (USD Million)
  • Table 35 Middle East & Africa: Parenteral Nutrition Bags Market, by Consumer, 2022-2031 (USD Million)
  • Table 36 Middle East & Africa: Parenteral Nutrition Bags Market, by End User, 2022-2031 (USD Million)
  • Table 37 Product Portfolio Analysis

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Parenteral Nutrition Bags Market, by Chamber Type, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Parenteral Nutrition Bags Market, by Consumer, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Parenteral Nutrition Bags Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Parenteral Nutrition Bags Market, by Geography
  • Figure 11 Impact Analysis of Market Dynamics
  • Figure 12 Percentage of Population Aged 65 Years or Over, by Region, 2022 Vs. 2030 (%)
  • Figure 13 Global Estimated Number of New Cancer Cases, 2020-2040 (In Million)
  • Figure 14 U.S. FDA Regulatory Pathways
  • Figure 15 India: Medical Device Regulatory Pathway
  • Figure 16 Porter's Five Forces Analysis
  • Figure 17 Global Parenteral Nutrition Bags Market, by Chamber Type, 2024 Vs. 2031 (USD Million)
  • Figure 18 Global Parenteral Nutrition Bags Market, by Consumer, 2024 Vs. 2031 (USD Million)
  • Figure 19 Global Parenteral Nutrition Bags Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 20 Global Parenteral Nutrition Bags Market, by Region, 2024 Vs. 2031 (USD Million)
  • Figure 21 North America: Parenteral Nutrition Bags Market Snapshot
  • Figure 22 Europe: Parenteral Nutrition Bags Market Snapshot
  • Figure 23 Asia-Pacific: Parenteral Nutrition Bags Market Snapshot
  • Figure 24 Latin America: Parenteral Nutrition Bags Market Snapshot
  • Figure 25 Middle East & Africa: Parenteral Nutrition Bags Market Snapshot
  • Figure 26 Parenteral Nutrition Bags Market: Competitive Benchmarking (Based on Chamber Type)
  • Figure 27 Parenteral Nutrition Bags Market: Competitive Benchmarking (Based on Geography)
  • Figure 28 B. Braun SE: Financial Overview (2022)
  • Figure 29 Baxter International, Inc.: Financial Overview (2023)
  • Figure 30 Fresenius Se & Co. KGaA: Financial Overview (2022)
  • Figure 31 GVS S.p.A.: Financial Overview (2022)
  • Figure 32 Grifols, S.A.: Financial Overview (2022)
  • Figure 33 RENOLIT SE: Financial Overview (2022)